Diagnostyka S.A. (Ticker: DIA PW) is a Poland-based provider of diagnostic services, operating in the medical labs and testing services industry. Established in 1998 and headquartered in Krakow, the company manages over 1,100 blood collection points and 156 laboratories across Poland, serving approximately 20 million patients annually.

Diagnostyka will list on the Warsaw Stock Exchange on February 7, 2025. The IPO involves the sale of 16.15 million secondary shares held by LX Beta S.à r.l., a company controlled by MidEuropa III Management Limited, which currently owns 47.83% of Diagnostyka. No new shares will be issued. The shares are priced at PLN 105.00 each, valuing the total offering at PLN 1.70 billion (USD 415.89 million).

The offering is managed by Citigroup Global Markets Limited, Bank Handlowy w Warszawie S.A. (Bank Handlowy Brokerage Office), Jefferies GmbH, Santander Bank Polska S.A. (Santander Brokerage Office), and Banco Santander, S.A., acting as joint global coordinators and joint bookrunners.